April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating of ...
Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...
March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...
March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization ...
March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a ...
March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left ...
February 24, 2021 — Occlutech announced the completion of patient enrollment in the PRELIEVE trial, pilot study to ...
January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...
January 25, 2021 — The U.S. Food and Drug Administration (FDA) approved Merck's Verquvo (vericiguat). It is the first ...
January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist ...
December 29, 2020 — Here is a list of the top 10 news stories from the European Society of Cardiology (ESC) in 2020 that ...
December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's HeartMate ...